Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Blood Types02:20

Blood Types

17.4K
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
17.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing the urgent need for clinical workload reform-a statement from the American Society of Pediatric Nephrology (ASPN).

Pediatric nephrology (Berlin, Germany)·2026
Same author

Use of extracorporeal membrane oxygenation in neonates with congenital anomalies of the kidney and urinary tract: a multicenter survey of current practices across CHNC and Pedi-ECMO centers.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Acute Kidney Replacement Therapy (KRT) in Pediatric Patients: A National Survey Assessing Nursing Structure and Standards in KRT Education.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association·2026
Same author

Pediatric Nephrology Practice in the United States: Survey of Pediatric Nephrology Division Directors.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2025
Same author

The Landscape of Pediatric Acute Care Nephrology Programs: A National Survey from the American Society of Pediatric Nephrology.

Kidney360·2025
Same author

Responding to the workforce crisis: consensus recommendations from the Second Workforce Summit of the American Society of Pediatric Nephrology.

Pediatric nephrology (Berlin, Germany)·2024

Related Experiment Video

Updated: May 30, 2025

Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.1K

Updates in atypical hemolytic syndrome.

Keri Drake1, Jyothsna Gattineni

  • 1Division of Pediatric Nephrology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Current Opinion in Pediatrics
|January 30, 2025
PubMed
Summary

Scientific advances in complement biology enhance the diagnosis and management of atypical hemolytic uremic syndrome (aHUS). Continued research offers insights into complement-mediated diseases for future therapeutic developments.

Keywords:
atypical hemolytic uremic syndromecomplement dysregulationcomplement inhibitorscomplement therapeuticsplasmapheresis

More Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

522
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K

Related Experiment Videos

Last Updated: May 30, 2025

Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.1K
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

522
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K

Area of Science:

  • Complement biology
  • Atypical hemolytic uremic syndrome (aHUS)
  • Complement-mediated diseases

Background:

  • Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening thrombotic microangiopathy.
  • Understanding complement system dysregulation is crucial for aHUS pathophysiology.

Purpose of the Study:

  • To review scientific advances in complement biology relevant to aHUS.
  • To highlight improvements in aHUS diagnosis and management.
  • To explore future therapeutic developments based on complement insights.

Main Methods:

  • Literature review of recent scientific advances in complement biology.
  • Synthesis of information on clinical, epidemiological, and pathophysiological aspects of aHUS.
  • Analysis of current and potential future therapeutic strategies.

Main Results:

  • Complement biology advancements have improved aHUS diagnosis and management.
  • Insights into complement-mediated disease pathophysiology are emerging.
  • Potential for novel therapeutic targets and strategies in aHUS treatment.

Conclusions:

  • Atypical hemolytic uremic syndrome (aHUS) necessitates prompt diagnosis and treatment.
  • Long-term management requires a multidisciplinary team approach.
  • Ongoing research in complement biology holds promise for improved aHUS patient outcomes.